Serial Number | 79111670 |
Word Mark | EXONHIT |
Filing Date | Wednesday, November 30, 2011 |
Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
Status Date | Tuesday, November 30, 2021 |
Registration Number | 4281253 |
Registration Date | Tuesday, January 29, 2013 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, November 13, 2012 |
Description of Mark | The mark consists of the wording "EXONHIT" in stylized format. "EXON" is in grey and "HIT" is in burgundy. |
Goods and Services | Pharmaceutical products for the treatment of diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; reagents and consumables for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents, consumables and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and, cancer; biopharmaceutical products, namely, reagents, consumables, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer ; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing Alzheimer disease and other neurodegenerative diseases and cancer, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely, probes and kits for medical and clinical diagnosis comprised of nucleic acid libraries and nucleic acids on DNA chips; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely, for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents contained in diagnostic test kits for medical use for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions |
Indication of Colors claimed | The color(s) grey and burgundy is/are claimed as a feature of the mark. |
Goods and Services | Chemical products and compositions, namely, nucleic acids attached to a solid medium for industrial and scientific use; fissile chemical elements intended for scientific research or laboratory research, namely, reagents, consumables, chemical entities and compounds; chemical preparations for nucleic acids attached to a solid medium for scientific purposes, chemical preparations for scientific analyses other than for medical or veterinary purposes; biological preparations other than for medical or veterinary purposes, namely, blood for the quantification of nucleic acid content; chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents or products for laboratory analyses, namely, nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for conducting research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, libraries of nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for leading research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, DNA fragments for decoding genes affected by diseases or for revealing the transcriptomic signature of patients affected by diseases, and DNA fragments for revealing and analyzing the expression of genes in connection with human medicine, pharmacological medicine and veterinary science |
Goods and Services | Medical services; veterinary services; medical assistance services; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry services, namely, to provide advice in the fields of biotechnology and pharmacy; and pharmacist's services to make up prescriptions, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services |
Goods and Services | Surgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, and measuring the progression of diseases, namely, Alzheimer disease and other neurodegenerative diseases, and cancer; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus intended for medical diagnosis, namely, materials for taking blood contained in kits for taking blood samples and comprised of medical instruments for taking blood; medical instruments for taking blood, collecting of DNA for diagnosing diseases, and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers; spoons for administering medicine; specially adapted containers for the application of medicines, namely, small bags and pouches for use in administering medicines; probes for medical purposes; syringes for medical purposes |
Goods and Services | Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues and blood samples; biotechnological scientific project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, August 30, 2019 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, August 30, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, August 30, 2019 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, August 30, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, August 30, 2019 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | DIAXONHIT |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | FR |
Party Name | EXONHIT S.A. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | FR |
Party Name | EXONHIT S.A. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | FR |
Event Date | Event Description |
Sunday, June 26, 2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
Sunday, June 26, 2022 | DEATH OF INTERNATIONAL REGISTRATION |
Friday, July 17, 2020 | TOTAL INVALIDATION PROCESSED BY THE IB |
Monday, June 15, 2020 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Monday, June 15, 2020 | INVALIDATION PROCESSED |
Thursday, April 30, 2020 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
Friday, August 30, 2019 | CANCELLED SECTION 71 |
Monday, January 29, 2018 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Thursday, November 20, 2014 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Saturday, May 25, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Monday, April 29, 2013 | FINAL DISPOSITION NOTICE SENT TO IB |
Monday, April 29, 2013 | FINAL DISPOSITION PROCESSED |
Monday, April 29, 2013 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, January 29, 2013 | REGISTERED-PRINCIPAL REGISTER |
Sunday, November 18, 2012 | NOTIFICATION PROCESSED BY IB |
Tuesday, November 13, 2012 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 13, 2012 | PUBLISHED FOR OPPOSITION |
Wednesday, October 24, 2012 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, October 24, 2012 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, October 24, 2012 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 9, 2012 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, October 5, 2012 | ASSIGNED TO LIE |
Saturday, September 22, 2012 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, September 21, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, September 21, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, September 21, 2012 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Monday, August 27, 2012 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, August 27, 2012 | FINAL REFUSAL E-MAILED |
Monday, August 27, 2012 | FINAL REFUSAL WRITTEN |
Monday, July 23, 2012 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, July 23, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, July 23, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, July 23, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, June 11, 2012 | REFUSAL PROCESSED BY IB |
Friday, May 18, 2012 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, May 18, 2012 | REFUSAL PROCESSED BY MPU |
Thursday, May 17, 2012 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, May 16, 2012 | NON-FINAL ACTION WRITTEN |
Monday, May 14, 2012 | ASSIGNED TO EXAMINER |
Tuesday, May 8, 2012 | APPLICATION FILING RECEIPT MAILED |
Friday, May 4, 2012 | ASSIGNED TO EXAMINER |
Friday, May 4, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, May 3, 2012 | SN ASSIGNED FOR SECT 66A APPL FROM IB |